Categories: News

ClareMedica Health Partners CEO, Roberto L. Palenzuela, Invited to Participate as a Tripletree “Market Insights Live” Panelist

MIAMI, FL / ACCESSWIRE / June 24, 2021 / ClareMedica Health Partners, LLC (“ClareMedica”) one of Florida’s premier health care organizations focused on the delivery of primary care to seniors, announced today that the company’s chief executive officer, Roberto L. Palenzuela, has been invited to participate as a TripleTree Market Insights Live panelist on June 29, 2021, at 11:00 a.m. Eastern.

Mr. Palenzuela will be discussing various aspects of the health care industry on a guest panel entitled “21st Century Primary Care” with a particular focus on the future of primary care and technology enabled solutions that will aid in its delivery.

The TripleTree Market Insights Live is virtual presentation and registration to attend is available by visiting: https://register.gotowebinar.com/register/396203932602044942?source=Web

About ClareMedica Health Partners

ClareMedica is a growing health care company that provides and coordinates comprehensive health care services for Medicare Advantage, Medicaid, and other customers through a network of employed and affiliated physicians. We deliver accountable care for all health care stakeholders by employing a patient-centric care model that adds value and provides solutions for a changing health care industry. With multiple locations in Central and South Florida, our health care network has over 100 providers and continues to grow. To learn more about ClareMedica Health Partners, LLC, please visit the company’s website at www.claremedica.com.

Contacts:

Al Palombo
Chief Marketing Officer
ClareMedica Health Partners, LLC
(786) 758-3133
albert@claremedica.com

SOURCE: ClareMedica Health Partners, LLC

View source version on accesswire.com:
https://www.accesswire.com/653076/ClareMedica-Health-Partners-CEO-Roberto-L-Palenzuela-Invited-to-Participate-as-a-Tripletree-Market-Insights-Live-Panelist

Staff

Recent Posts

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

11 minutes ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

2 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

2 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

2 hours ago

CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS

 Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…

2 hours ago

Medit Launches a Mobile App, MEDIT M, to Revolutionize Digital Dental Workflows

SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…

2 hours ago